ANI Pharma (ANIP) Acquires NDA for Testosterone Gel 1% from Teva (TEVA)
Tweet Send to a Friend
ANI Pharmaceuticals, Inc.(NASDAQ: ANIP) announced that it has acquired the approved new drug application for a testosterone gel 1% product ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
